{{Rsnum
|rsid=1351383
|Gene=PSMB9
|Chromosome=6
|position=32854492
|Orientation=minus
|GMAF=0.4045
|Gene_s=PSMB9,TAP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 11.5 | 49.6 | 38.9
| HCB | 9.6 | 56.6 | 33.8
| JPT | 12.4 | 46.9 | 40.7
| YRI | 22.4 | 52.4 | 25.2
| ASW | 22.8 | 45.6 | 31.6
| CHB | 9.6 | 56.6 | 33.8
| CHD | 15.6 | 45.9 | 38.5
| GIH | 12.9 | 51.5 | 35.6
| LWK | 17.4 | 60.6 | 22.0
| MEX | 25.9 | 41.4 | 32.8
| MKK | 14.7 | 49.4 | 35.9
| TSI | 14.7 | 56.9 | 28.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=23360169
|Title=Association between putative functional variants in the PSMB9 gene and risk of melanoma - re-analysis of published melanoma genome-wide association studies
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}